StreetAlpha.app
Home › Stocks › FRNM

Freenome, Inc. (FRNM)

$9.82
▼ −2.68%
LAST CLOSE · NOV 17

Freenome is a blank check company seeking to combine with a healthcare, life sciences or medical technology business. It last closed at $9.82 on Nov 17, down 2.68% on the day. FRNM reports earnings on Wed, Dec 2, 2026. In the past 30 days there were 1 dark pool print totaling $1.5M, the largest $1.5M.

AI Auto Pilots
Is FRNM in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
$109.4M
Valuation
Market cap
$1.1B
111.5M shares
P/E
–
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$180.4M
At Sep 30
Shareholder equity
$481.3M
Shares outstanding
111.5M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
Sep ’25: $1.0M$1.0MSep ’25Sep ’26: $183.5M$183.5MSep ’26

From FRNM's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Dec 2
2026 · Time not announced
Consensus EPS forecast
$0.14
$84.9M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated FRNM in the past 90 days, not enough for a consensus
Average 12-month target
$21.00
▲ 113.8% upside

Based on 1 analyst who set a price target on FRNM in the past 90 days. The average target is $21.00, with a high of $21.00 and a low of $21.00, compared with the last close of $9.82.

Low $21.00Avg $21.00High $21.00
Blue marker: last close $9.82
Highest target$21.00
Average target$21.00
Lowest target$21.00
Latest rating changes
GuggenheimInitiated
Aug 20Buy$21
TD CowenInitiated
Aug 18Buy$17
JefferiesInitiated
Aug 17Buy$17
BTIGInitiated
Aug 17Buy$17
Leerink PartnersInitiated
Aug 14Buy$18
DateFirmActionRatingPrice target
Aug 20GuggenheimInitiatedBuy$21
Aug 18TD CowenInitiatedBuy$17
Aug 17JefferiesInitiatedBuy$17
Aug 17BTIGInitiatedBuy$17
Aug 14Leerink PartnersInitiatedBuy$18
Loading…

Technical Analysis

FRNM · as of the Nov 17 close · updated after every close
Falling, nearing oversold

The stock is 19% below its 20 day and 40% below its 50 day average. Momentum is weak (RSI 33), near oversold. The nearest support is the 52 week low at $9.71, and the nearest resistance the Pivot at $10.04.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.4%/day
Key levels
$17.5052 week high+78.2%
$13.7250 day average+39.7%
$13.05100 day average+32.9%
$11.6620 day average+18.7%
$11.40Swing high (Jun 25)+16.1%
$10.34Pivot R1+5.3%
$10.04Pivot+2.2%
$9.82Last close
$9.7152 week low−1.1%
$9.71Swing low (Nov 6)−1.1%
$9.52Pivot S1−3.1%
Indicators
RSI (14)32.55Weak, oversold below 30Neutral
MACD-1.00Below its signal lineBearish
Stochastic9.9Near the bottom of its rangeOversold
ADX (14)30.6Trending down
Williams %R-97.2Oversold below −80, overbought above −20Oversold
CCI (20)-100.6Oversold below −100, overbought above 100Oversold
Rate of change−14.4%Change over 10 sessionsBearish
ATR (14)$0.93Typical daily range, 9.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for FRNM

What happened before

See how FRNM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Earnings in 14 daysSignals right before a report are less reliable. The report can override them.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in FRNM in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$1.5M
Largest print
$1.5M
Loading…

FRNM Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲72 buying vs 27 selling
  • ▲Held by funds +63.4 pts
  • ▲Funds holding +45
  • ▲Superinvestors: 5 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding7227+166.7%
In funds' top 1040–
Held by funds71.4%8.0%+63.4 pts
New / increased72 / 07 / 8+380.0%
Reduced / sold out0 / 273 / 14+58.8%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FRNM institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FRNM is in one of them and how their past FRNM trades turned out.

FRNM in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FRNM in an article yet. Here's the latest on the wider market.

About Freenome

Freenome is a blank check company, a shell formed to acquire or combine with an operating business. It has no operating revenue yet and is focused on healthcare, especially life sciences and medical technology companies in North America or Europe. The company has entered into an agreement for a business combination with Freenome Holdings, Inc., which is subject to closing conditions. Freenome is based in Brisbane, California.

Headquarters
Brisbane, CA